Hyperhomocysteinemia, atherosclerosis and arterial and venous thrombosis;Hyperhomocysteinemie, atherosclerose et thromboses arterielles et veineuses

Annales de Medecine Interne

Volumn 147, Issue 5, 1996, Pages 352-360

  Cacoub, Patrice ^a   Gatel, Anne ^a   Sbai, Abdallah ^a   Piette, Jean Charles ^a   Godeau, Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ARTERY THROMBOSIS; ATHEROSCLEROSIS; HETEROZYGOSITY; HUMAN; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VEIN THROMBOSIS; ANIMAL; ARTERIOSCLEROSIS; BLOOD; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HETEROZYGOTE; HOMOZYGOTE; METABOLISM; THROMBOSIS;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; ARTERIOSCLEROSIS; HETEROZYGOTE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; THROMBOSIS;

EID: 0029821546     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. CARSON NAJ, NEIL DW : Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962 ; 37: 505-13.
2. MUDD SH, FlNKELSTElN JD, IRREVERRE F, LASTER L : Ho- mocystinuria : an enzymatic defect. Science 1964; 17 : 427-37.
3. MCCULLY KS : Vascular pathology of homocysteinemia : implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969 ; 56 : 111-28.
4. McCuLLY KS, WILSON RB : Homocystinuria theory of arteriosclerosis. Atherosclerosis 1975 ; 22 : 215-27.
5. Wilscken DEL, Wilcken B : The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976 ; 57 : 1079-82.
6. CHRISTENSEN B, REFSUM H, VINTERMYR O, UELAND PM ; Homocysteine export from cells cultured in the presence of physiological or superflous levels of methionine : methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture. J Cell Physiol 1990 ; 146 : 52-62.
7. WILCKEN DEL, REDDY SG, GUPTA VJ : Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism 1983 ; 32 : 363-70.
8. BOERS GHJ, SMALS AGH, TRUBELS FJM et al. : Heterozygosity for homocystinuria in premature peripheral ane cerebral occlusive arterial disease. N Engl J Med 1985 : 313 : 709-15.
9. UBBINK JP, VAN DER MERWE A, VERMAAK WJ, DELPORT R : Hyperhomocysteinemia and the response to vitamin supplementation. Clin Invest 1993 ; 71 : 993-8.
10. CHAUVEAU P, CHADEFAUX B, COUDÉ M et al. : Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993 ; 43 (suppl 41) : 72-7.
11. Ueland P, Refsum H : Plasma homocysteine risk factor for vascular disease : plasma levels in health disease and drug therapy. J Lab Clin Med 1989 ; 114 : 473-501.
12. BRENTON DP, CUSWORTH DC, GAULL GE : Homocystinuria : metabolic studies on 3 patients. J Pediatr 1965 ; 67: 58-68.
13. CLARKE R, DALY L, ROBINSON DK et al. : Hyperhomocysteinemia : an independent risk factor for vascular disease. N Engl J Med 1991 ; 324 : 1149-55.
14. CALABRESE EJ : Environmental validation of the homocysteine theory of arteriosclerosis. Med Hypotheses 1984 ; 15: 361-7.
15. MUDD SH : Vascular disease and homocysteine metabolism. N Engl J Med 1985 ; 313 : 751 -3.
16. MUDD SH, SKOVBY F, LEVY HL et al. : The natural history of homocystinuria due to cystationine beta-synthetase deficiency. Am J Human Genet 1985 ; 37 : 1-31.
17. McCULLY KS, RAGSDALE BD : Production of arteriosclerosis by homocysteinemia. Am J Pathol 1970 ; 61 : 1-11.
18. MUDD SH, LEVY HL, SKOVBY F : Disorders of transsulfuration. In : SCRIVER CR, BEAUDET AL., SLY WS, VALLE D, eds. The metabolic basis of inherited disease. 6th ed. New York : Me Graw-Hill, 1989 ; 693-734.
19. NORDSTÖM M, KJELLSTRÖM T : Age dependency of cystathionine beta-synthase activity in human fibroblast in homocyst(e)inemia and atherosclerotic vascular disease. Atherosclerosis 1992 ; 94 : 213-21.
20. MCGILL JJ, METTLER G, ROSENBLATT DS, SCRIVER CR : Detection of heterozygotes fort recessive alleles. Homocyst(e)inemia : paradigm of pitfalls in phenotypes. Am J Med Genet 1990 ; 36 : 45-52.
21. KOZICH V, KRAUS JP : Screening for mutations by expressing patient cDNA segments in E. coli : homocystinuria due to cystathionine beta-synthase deficiency. Human Mutut 1992 ; 1 : 113-23.
22. KRAUS JP, LE K, SWAROOP M et al. : Human cystathionine beta-synthase cDNA : sequence, alternative splicing and expression in cultured cells. Hum Mol Genet 1993 ; 10 : 1633-8.
23. KOZICH V, KRAUS E, DE FRANCHIS R et al. : Hyperhomocysteinemia in premature arterial disease : examination of cystathionine beta-synthase alleles at the molecular level. Hum Mol Genet 1995 ; 4 : 623-9.
24. SEBASTIO G, SPKRANDEO MP, PANICO M, DE FRANCHIS R, KRAUS JP, ANDRIA G : The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995 ; 56 : 1324-33.
25. KLUIJTMANS LAJ, BLOM HJ, BOERS GHJ et al. : Two novel missence mutations in the cystathionine beta-synthase gene in homocystinuric patients. Hum Genet 1995 ; 96 : 249-50.
26. Hu FL, Gu Z, KOZICH V, KRAUS JP, RAMESH V, SHIH VE : Molecular basis of cystathionine beta-synthase deficiency in pyridoxine reponsive and nonresponsivbe homocystinuria. Hum Mol Genet 1993 ; 2 : 1857-60.
27. MUDD SH, POOLE JR : Labile methyle balances for normal humans on various dietary regimens. Metabolism 1975 ; 24 : 721-35.
28. REFSUM H, HELLAND S, UELAND PM : Radioenzymatic determination of homocysteine in plasma and urine. Clin Chem 1985 ; 31 : 624-8.
29. BRATTSTRÖM L, ISRAELSSON, LINDGARDE F, HUTBERG B : Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism 1988 ; 37: 175-8.
30. KANG SS, WONG PWK, NORUSIS M : Homocysteinemia due to folate deficiency. Metabolism 1987 ; 36 : 458-62.
31. ISRAELSSON B, BRATTSTRÖM LE, HULTBERG B: Homocysteine and myocardial infarction. Atherosclerosis 1988 ; 71 : 227-33.
32. MALINOW MR, RANG SS, TAYLOR LM et al. : Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989 ; 79 : 1180-8.
33. BRATTSTRÖM L, ISRAELSSON B, JEPPSSON JO, HULTBURG BL : Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988 ; 48 : 215-21.
34. MCCULLY KS : Homocysteine theory of arteriosclerosis : development and current status. GOTTO AM, PAOLETTI R (eds). Atherosclerosis Rev 1983 ; 11 : 157-249.
35. KANG SS, WONG PWK, COOK HY, NORUSIS M, MESSER JV : Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 1986 ; 77: 1482-6.
36. WILCKEN DEL, WILCKEN B, DUDMAN NPB, TYRRELL PA : Homocystinuria. The effect of betaine in the treatment of patients not responsive to pyridoxine. N EngL J Med 1983 ; 309: 448-53.
37. MALINOW MR : Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990 ; 81 : 2004-6.
38. MALINOW MR : Plasma homocyst(e)ine and arterial occlusive diseases : a mini-review. Clin Chem 1994 ; 40 : 173-6.
39. HARKER LA, HARLAN JM, Ross R : Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ ReS 1983 ; 53 : 731-9.
40. COULL BM, MALINOW MR, BEAMER N et al. : Elevated plasma homocyst(e)ine in acute stroke and TIA : a possible independent risk factor for stroke. Stroke 1990 ; 21 : 572-6.
41. GLUECK CJ, SHAW P, LANG JE et al. : Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995 ; 75 : 132-6.
42. GENNETS JJ, MCNAMARA JR, SALEM DN, WILSON PWF, SCHAEFER EF, MALINOW MR : Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990 ; 16 : 1114-9.
43. BRATTSTRÖM L, HARDEBO JE, HULTBERG BL : Moderate homocysteinemia : a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984 ; 15 : 1012-6.
44. MALINOW MR, NIETO FJ, SZKLO M, CHAMBLESS LE, BOND G : Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults : the Atherosclerosis Risk in Communities Study. Circulation 1993 ; 87: 1107-13.
45. STAMPFER MJ, MALINOW MD, WILLETT WD et al. : A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992 ; 7 : 877-81.
46. MEDRANO MJ, BARRADO MJ, ALMAZAN J : Is hyperhomocysteinemia a risk factor for venous thrombosis and atherosclerotic vascular diseases ? Lancet 1995 ; 346 : 127.
47. ARNESEN E, REFSUM H, BONAA KL et al. : The Thrombo Study : serum total homocysteine and myocardial infarction : a prospective study. Presented at the 3rd Internation Conference on Preventive Cardiology, Oslo, Norway, June 27-July i, 1993, abstract.
48. SELHUB J, JACQUES PF, BOSTOM AG et al. : Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995 ; 332 : 286-91.
49. PERRY IJ, REFSUM H, MORRIS RW, EBRAHIM SB, UELAND PM, SHAPER AG : Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995 ; 346 : 1395-8.
50. ALFTHAN G, PEKKANEN J, JAUHIAINEN M et al. : Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994 ; 706 : 9-19.
51. TAYLOR LM, DEFRANG RD, HARRIS EJ, PORTER JM : The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vase Surg 1991 ; 13 : 128-36.
52. ARONSON DC, ONKENHOUT W, RABEN AM et al. : Impaired homocysteine metabolism : a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg. Br J Surg 1994 ; 81 : 1114-8.
53. MOLGAARD J, MALINOW MR, LASSVIK C et al. : Hyperhomocyst(e)inaemia : an independent risk factor for intermittent claudication. J Int Med 1992 ; 231 : 273-9.
54. BRATTSTRÖM L, TENGBORN L, ISRAELSSON B, HULTBERG B : Plasma homocysteine in venous thromboembolism. Haemostasis 1991 ; 21 : 51-7.
55. BIENVENU T, ANKRI A, CHADEFAUX B, KAMOUN P : Plasma homocysteine assay in the exploration of thrombosis in young subjects. Presse Med 1991 ; 20 : 985-8.
56. FALCON CR, CATTANEO M, PANZERI D, MARTINELLI I. MUNNUCCI PM : High prevalence of hyperhomocyst(e)inemia in patients with juvenil venous thrombosis. Arterioscl Throm 1994 ; 14 : 1080-3.
57. DEN HEIJER M, BLOM HJ, GERRITS WBJ et al. : Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis ? Lancet 1995 ; 345 : 882-5.
58. MCCULLY KS : Atherosclerosis, serum cholesterol and the homocysteine theory : a study of 194 consecutive autopsies. Am J Med Sci 1990 ; 299 : 217-21.
59. TSAI JC, PERRELLA MA, YOSHIZUMI M et al. : Promotion of vascular smooth muscle cell growth by homocysteine : a link to atherosclerosis. Proc Natl Acad Sci USA 1994 ; 91 : 6369-73.
60. HARPEL PC, CHANG VT, BORTH W : Homocysteine and other sulfhydryl compounds enhance the binding of liporotein(a) to fibrin : a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 1992 ; 89: 10193-7.
61. STAMLER JS, OSBORNE JA, JARAKI O et al. : Adverse vascular effects of homocysteine are modulated by endotheliumderived relaxing factor and related oxides of nitrogen. J Clin Invest 1993 ; 91 : 308-18.
62. McCuLLY KS : Macromolecular basis for homocysteine-induced changes in proteoglycan structure in growth and arteriosclerosis. Am J Pathol 1972 ; 66 : 83-96.
63. LENTZ SR, SADLER JE : Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991 ; 88 : 1906-14.
64. RODGERS GM, KANE WH, PITAS RE : Formation of factor Va by atherosclerosis rabbit aorta mediates factor Xa-catalyzed prothrombin activation. J Clin Invest 1998 ; 81 : 1911-9.
65. LENTZ SR, SADLER JE : Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 1993 ; 81 : 683-9.
66. FRYER RH, WILSON BD, GUBLER DB, FITZZGERALD LA, RODGERS M : Homocysteine, a risk factor for premature vascular disease and thrombosis, induced tissue factor activity in endothelial cells. Arterioscl Thromb 1993 ; 13 : 1327-33.
67. FRANKEN DG, BOERS GHJ, BLOM HJ, TRIJBELS FJM, KLOPPENBORD PW : Treatment of mild hyperhomocysteinemia in vascular disease patients. Arteroscl Thromb 1994 ; 14 : 465-70.
68. SELHUB J, JACQUES PF, WILSON PW, RUSH D, ROSENBERG IH : Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993 ; 270: 2693-8.
69. WILCKEN DEL, DUDMAN NPB, TYRRELL PA, ROBERTSON MR : Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency : possible implications for prevention of vascular disease. Metabolism 1988 : 37: 697-701.
70. STAMPFER MJ, WILLETT WC : Homocysteine and marginal vitamin deficiency - the importance of adequate vitamin intake. JAMA 1993 ; 270 : 2726-7.
71. DEN HEUER M, Bos GMJ, GERRITS WBJ, BLOM HJ : Will a decrease in blood homocysteine by vitamin supplementation reduced the risk for vascular disease ? Fibrinolysis 1994:8 (suppl 2):91-2.